Alzamend Neuro, Inc. (ALZN) Q1 2025 Earnings
ALZN·Reported March 10, 2025·Before market open
Diluted EPS came in at $-1.71, beat the $-2.61 consensus by $0.90.
Diluted EPS
$-1.71beat by $0.90
Consensus: $-2.61
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Alzamend Neuro, Inc.'s Q1 2025 earnings report.
Alzamend Neuro, Inc. (ALZN) reported Q1 2025 earnings on March 10, 2025 before market open.
Alzamend Neuro, Inc. reported diluted EPS of $-1.71 for Q1 2025.
EPS beat the consensus estimate of $-2.61 by $0.90.
You can read the 10-Q periodic report (0001214659-25-004123) directly on SEC EDGAR. The filing index links above go to sec.gov.